Krystal Biotech Inc
KRYS
Market Cap$3.64B
Close$
$207.42
56.4% upside
Current Fair Value
56.4% upsideUndervalued by 56.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.64 Billion |
|---|---|
| Enterprise Value | $3.35 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.12 |
| Beta | 0.78 |
| Outstanding Shares | 28,815,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 29.28 |
|---|---|
| PEG | 0.78 |
| Price to Sales | 12.06 |
| Price to Book Ratio | 3.9 |
| Enterprise Value to Revenue | 10.05 |
| Enterprise Value to EBIT | 28.05 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data